Definitive Healthcare, an industry leader in healthcare commercial intelligence, today announced the general availability of Monocl ExpertInsight 2.0, the next generation of the company’s expert identification product, and a new mobile app, Monocl ExpertGO. These new offerings give medical affairs professionals access to nearly 13 million expert profiles globally so they can more quickly identify and engage the right scientific experts to provide critical insights that can accelerate the drug development process.

Monocl ExpertInsight 2.0 provides an optimized user experience that helps medical affairs teams increase productivity, streamline workflows and develop more informed medical strategies.

“We’re passionate about helping medical affairs teams find the right experts who can help accelerate time to market for a new drug or medical device,” said Robert Musslewhite, president of Definitive Healthcare.

As part of this latest release, Definitive Healthcare also added Brazilian expert data to the Monocl ExpertInsight database to help life sciences teams gain a deeper understanding of the South American market.

At Definitive Healthcare, our passion is to transform data, analytics and expertise into healthcare commercial intelligence.